Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Bortezomib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 25 Immunoglobulin Light-chain Amyloidosis 5 Paraproteinemias 2 Neoplasms, Plasma Cell 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Renal Insufficiency 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 HIV Infections 1 Anemia, Sickle Cell 1 Amyloidosis 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 18 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 10 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Fluorouracil 6 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Immunoglobulin G 3 Fulvestrant 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiosurgery 2 Radiation 2 Protons 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡